Drug Pricing Reform: Now It Is HHS Secretary Becerra’s Turn
Executive Summary
After months of reticence about his Administration's plans for tackling drug pricing, Biden's executive order offers some clues about what might be in store and what kind of timeline they are working with.
You may also be interested in...
Another Drug Pricing Executive Order?!
President Joe Biden defines himself as the opposite of Donald Trump. But they appear to share a fondness for Executive Orders on drug pricing.
US Senators Urge PTO’s Vidal To Tackle Pharma Patent Thickets
A bipartisan group of senators has written to the US Patent and Trademark Office, urging it to tackle the impact of patent thickets on the generic and biosimilar drug industries.
Biosimilars Forum Calls For Further Action On Biden’s Competition Order
Generics Bulletin sits down with Biosimilars Forum executive director Julie Reed to discuss preparing the HHS for Humira biosimilars, what more the agency could do for the industry and the Forum’s priorities over the next year.